+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are evaluating the long-term safety and effectiveness of DISCOGEL4, a gelified ethanol device, compared with intradiscal steroid infiltration for treating refractory lumbar discogenic pain. This study is designed as a randomized, prospective, single-blind clinical trial involving patients who have chronic discogenic pain not responding to conservative treatments. The trial aims to confirm previous clinical data from over 600 patients by monitoring a larger group over two years. Participants will be randomly assigned to receive either a single intradiscal injection of DISCOGEL4 0.6 to 2.2 ml or a single injection of the authorized steroid drug Hydrocortancyl 2.5% 0.2 to 2.0 ml. Both treatments are used according to their approved instructions. The study includes a comparison of short-term efficacy at 3 months and long-term efficacy and safety up to 24 months. Economic data and procedure durations will also be collected. During the study, participants will undergo various assessments including questionnaires Oswestry and MacNab, radiography, and magnetic resonance imaging at multiple time points 3, 12, and 24 months. Researchers will monitor both short-term and long-term safety and efficacy, as well as procedure-related factors. The total follow-up period extends to two years, ensuring comprehensive evaluation of treatment effects and participant well-being throughout the study.

Age: 18Years +All GendersPhase Not Applicable
5 locations
O

Actively Recruiting

Researchers are studying the effects of monitoring both sedation and analgesia during anesthesia in patients aged 75 and older who are at high risk for complications after surgery. The goal is to see if this combined monitoring can reduce intraoperative hypotension and improve postoperative outcomes, including organ dysfunction and mortality. This study is a controlled, randomized trial conducted at multiple centers to evaluate the benefit of carefully managing hypnotic and opioid drugs during high-risk surgeries. Participants will be randomly assigned to one of two groups. One group receives anesthesia guided by special monitoring systems that track sedation levels and pain response using devices like BIS9, SedLineae, Entropy Sensor1, and PMD-200ae. The other group receives anesthesia based on the anesthetists usual clinical judgment without these monitors. Both groups undergo general anesthesia with hypnotic and opioid drugs and airway management. During the study, participants will be followed closely for 30 days after surgery to assess outcomes such as death, kidney injury, cardiovascular and neurological complications, and delirium. Researchers will also track doses of anesthetic drugs, periods of low blood pressure during surgery, pain levels after surgery, and other recovery measures. The study includes detailed monitoring of drug use and vital signs during surgery to understand how monitoring affects patient safety and recovery.

Age: 75Years +All GendersPhase Not Applicable
20 locations